Articles Referencing HITK

GuruFocus

The Royce Funds Makes Moves on Some Tech Stocks

As of Nov. 30, New York-based Royce Funds, headed by small-cap value investor, Chuck Royce , has reported six trades, four of them from the technology sector. The two other non-tech stocks... Read >>

NASDAQ.com News

Hi-Tech Pharmacal Co., Inc. (HITK) Ex-Dividend Date Scheduled for December 11, 2012

Hi-Tech Pharmacal Co., Inc. ( HITK ) has announced an ex-dividend date of December 11, 2012 and a cash dividend payment of $1.5 per share scheduled for December 28, 2012. Shareholders who... Read >>

NASDAQ.com News

Pre-Market Earnings Report for December 6, 2012 : TD, CM, LULU, HRB, SFD, UTIW, CMN, KFY, TITN, LAYN, HITK, MEI

The following companies are expected to report earnings prior to market open on 12/06/2012. Visit our Earnings Calendar for a full list of expected earnings releases. Toronto Dominion Bank (... Read >>

NASDAQ.com News

Pre-Market Earnings Report for July 10, 2012 : SHAW, WWW, HELE, HITK, PENX, LEDS

The following companies are expected to report earnings prior to market open on 07/10/2012. Visit our Earnings Calendar for a full list of expected earnings releases. Shaw Group Inc. ( SHAW... Read >>

Validea

Looking for Cinderallas in the Stock Market

March Madness is upon us and the big question on every college basketball fan's mind is, who will play Cinderella in this year's NCAA tournament? Every year, smaller schools and other... Read >>

Kapitall

Momentum Ideas: 10 Stocks With Encouraging Inventory Trends

( Written by Rebecca Lipman. List compiled by Eben Esterhuizen, CFA. Accounting data sourced from Google Finance, all other data sourced from Finviz.) Are you looking for companies that are... Read >>

Kapitall

Investing 101: Stocks Reaching New Highs with Institutional Buying

( Article by Becca Lipman. List compiled by Eben Esterhuizen, CFA. Data sourced from Fidelity) Do you prefer to invest with the trend? If so the following list may be of interest to you. ... Read >>

Kapitall

Generics on the Rise: A Big Threat to Big Pharma?

(Written by Alexander Crawford. Data sourced from Finviz.) Pfizer’s Lipitor, the best-selling drug worldwide for several years running, loses its U.S patent status this November. The... Read >>